comparemela.com
Home
Live Updates
Biocytogen Enters into MultiTarget Antibody Agreement With Neurocrine Biosciences : comparemela.com
Biocytogen Enters into MultiTarget Antibody Agreement With Neurocrine Biosciences
Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 today announced that it has entered into an antibody evaluation and option agreement with Neurocrine Biosciences Inc.
Related Keywords
Shanghai ,
China ,
San Diego ,
California ,
United States ,
San Francisco ,
Beijing ,
Jude Onyia ,
Neurocrine Biosciences ,
Yuelei Shen ,
Haimen Jiangsu ,
Biocytogen Pharmaceuticals Beijing Co Ltd ,
Neurocrine Biosciences Inc ,
Chief Scientific Officer ,
Media Contact ,
Biocytogen Antibody Agreement Neurocrine Biosciences Pharmaceuticals Evaluation Renmice Dr Yuelei Shen Human Antibodies Biopharmaceutical Neurological Diseases Jude Onyia Biotechnology Gene Editing Technology Renmab Renlite Rennano Rentcrmimic Preclinical Research Biomice ,
comparemela.com © 2020. All Rights Reserved.